- Hong Kong
- /
- Healthcare Services
- /
- SEHK:401
Wanjia Group Holdings (HKG:401) Might Have The Makings Of A Multi-Bagger
If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, we've noticed some promising trends at Wanjia Group Holdings (HKG:401) so let's look a bit deeper.
Understanding Return On Capital Employed (ROCE)
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Wanjia Group Holdings, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.015 = HK$2.9m ÷ (HK$228m - HK$34m) (Based on the trailing twelve months to September 2021).
So, Wanjia Group Holdings has an ROCE of 1.5%. In absolute terms, that's a low return and it also under-performs the Healthcare industry average of 12%.
View our latest analysis for Wanjia Group Holdings
While the past is not representative of the future, it can be helpful to know how a company has performed historically, which is why we have this chart above. If you're interested in investigating Wanjia Group Holdings' past further, check out this free graph of past earnings, revenue and cash flow.
What Can We Tell From Wanjia Group Holdings' ROCE Trend?
It's great to see that Wanjia Group Holdings has started to generate some pre-tax earnings from prior investments. While the business is profitable now, it used to be incurring losses on invested capital five years ago. At first glance, it seems the business is getting more proficient at generating returns, because over the same period, the amount of capital employed has reduced by 44%. This could potentially mean that the company is selling some of its assets.
One more thing to note, Wanjia Group Holdings has decreased current liabilities to 15% of total assets over this period, which effectively reduces the amount of funding from suppliers or short-term creditors. So this improvement in ROCE has come from the business' underlying economics, which is great to see.
The Bottom Line
In the end, Wanjia Group Holdings has proven it's capital allocation skills are good with those higher returns from less amount of capital. Although the company may be facing some issues elsewhere since the stock has plunged 89% in the last five years. Regardless, we think the underlying fundamentals warrant this stock for further investigation.
One more thing, we've spotted 2 warning signs facing Wanjia Group Holdings that you might find interesting.
If you want to search for solid companies with great earnings, check out this free list of companies with good balance sheets and impressive returns on equity.
Valuation is complex, but we're here to simplify it.
Discover if Wanjia Group Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:401
Wanjia Group Holdings
An investment holding company, engages in pharmaceutical wholesale and distribution business in the Mainland China and Hong Kong.
Flawless balance sheet and good value.